03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The novel coronavirus (COVID-19) has implications for multiple workplace concerns, including health ...
Read More >
Seyfarth Synopsis: Waterloo, Iowa has enacted the state’s first “Ban the Box” Ordinance....By: S...
Read More >
The COVID-19 pandemic is impacting every facet of the economy, including commercial construction and...
Read More >
The Department of Labor (“DOL”) has revised its Overtime Rule that updates the earnings thresholds...
Read More >
The achievement of legislative consensus in 2018 around a preferred approach to safeguarding U.S. te...
Read More >
On September 23, 2019, the National Labor Relations Board (NLRB) published a Notice of Proposed Rule...
Read More >